Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PRINS, T. J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 14 of 14

  • Page / 1
Export

Selection :

  • and

Hafnium halide compounds of methyl substituted allyl ligands. Synthesis, crystal structure and dynamics of (η5-C5Me5)(η3-1,2,3-Me3allyl)HfBr2 and (η5-C5Me5)(η3-1,1,2-Me3allyl)HfBr2HAUGER, B. E; VANCE, P. J; PRINS, T. J et al.Inorganica chimica acta. 1991, Vol 187, Num 1, pp 91-97, issn 0020-1693Article

Structure-based design of novel, urea-containing FKBP12 inhibitorsDRAGOVICH, P. S; BARKER, J. E; PELLETIER, L. A. K et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 9, pp 1872-1884, issn 0022-2623Article

Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitorZALMAN, L. S; BROTHERS, M. A; DRAGOVICH, P. S et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 5, pp 1236-1241, issn 0066-4804Article

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studiesDRAGOVICH, P. S; WEBBER, S. E; TIKHE, J et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 15, pp 2819-2834, issn 0022-2623Article

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacementsDRAGOVICH, P. S; PRINS, T. J; BURKE, B. J et al.Journal of medicinal chemistry (Print). 1999, Vol 42, Num 7, pp 1213-1224, issn 0022-2623Article

In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C proteasePATICK, A. K; BINFORD, S. L; FUHRMAN, S. A et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 10, pp 2444-2450, issn 0066-4804Article

A conformation study of peptides with the general structure Ac-L-Xaa-Pro-D-Xaa-L-Xaa-NH2 : spectroscopic evidence for a peptide with significant β-turn character in water and in dimethyl sulfoxideIMPERIALI, B; FISHER, S. L; MOATS, R. A et al.Journal of the American Chemical Society. 1992, Vol 114, Num 9, pp 3182-3188, issn 0002-7863Article

Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitorsDRAGOVICH, P. S; RU ZHOU; MEADOR, J. W et al.Bioorganic & medicinal chemistry letters (Print). 2000, Vol 10, Num 1, pp 45-48, issn 0960-894XArticle

Chemoenzymatic synthesis of 2-amino-3-(2,2'-bipyridinyl)propanoic acidsIMPERIALI, B; PRINS, T. J; FISHER, S. L et al.Journal of organic chemistry. 1993, Vol 58, Num 6, pp 1613-1616, issn 0022-3263Article

Effect of allyl methyl substituents on the preparation, dynamics, and reactivity of (η5-C5Me5)(allyl)ZrX2 complexes (X = Cl, Br): Structure of (η5-C5Me5)(C3H5)ZrCl2 and (η5-C5Me5)(1,2-Me2(butadiene))(η2-CH2PPh2)Zr. Dynamics of (η5-C5Me5)(2,3-Me2(butadiene))(η2-CH2PPh2)ZrVANCE, P. J; PRINS, T. J; MCCANDLESS, J. J et al.Organometallics. 1991, Vol 10, Num 4, pp 917-924, issn 0276-7333, 8 p.Article

Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acidsDRAGOVICH, P. S; WEBBER, S. E; BROWN, E. L et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 15, pp 2189-2194, issn 0960-894XArticle

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimeticsDRAGOVICH, P. S; PRINS, T. J; ZHOU, R et al.Journal of medicinal chemistry (Print). 1999, Vol 42, Num 7, pp 1203-1212, issn 0022-2623Article

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studiesDRAGOVICH, P. S; WEBBER, S. E; LITTLEFIELD, E. S et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 15, pp 2806-2818, issn 0022-2623Article

Cyclopentadienyl(allyl)(butadiene)hafnium compounds. Synthesis, crystal structure, and dynamics of cyclopentadienyl(1,2,3-trimethylallyl)(1,2-dimethylbutadiene)-hafnium and cyclopentadienyl(1,1,2-trimethylallyl)-(2,3-dimethylbutadiene)hafniumPRINS, T. J; HAUGER, B. E; VANCE, P. J et al.Organometallics. 1991, Vol 10, Num 4, pp 979-985, issn 0276-7333, 7 p.Article

  • Page / 1